Omega Healthcare Investors reports Tuesday with short interest minimal but options traders turning increasingly bullish. Put/call ratio has fallen sharply below its 20-day average, signalling reduced hedging demand.
Short interest stands at 3.93% of float as of April 23. Days to cover is 5.87 based on FINRA data. Cost to borrow sits at just 0.37%, down 19% over the past week. Utilisation remains light at 2.02%, well below the 52-week high of 6.76%. Short sellers have added modestly to positions over the past week, up 0.57%, but trimmed exposure 7.6% over the past month.
The put/call ratio was 1.15 on April 24, well below the 20-day mean of 1.47. The current PCR sits 1.6 standard deviations below average, indicating unusually call-heavy positioning. That places it near the bottom of the 52-week range, which spans 0.36 to 2.16. Options traders have rotated sharply toward calls in recent sessions.
The consensus rating is Hold, with 10 hold ratings and one underperform out of a total analyst cohort. The mean price target is $49.38, implying upside from the current $46.41 close. B of A Securities downgraded OHI to Underperform on April 14, cutting its target to $46 from $52. Wells Fargo raised its target to $47 from $45 on March 26, maintaining Equal-Weight. Truist lifted its hold target to $48 from $46 on March 5. Cantor Fitzgerald raised to $52 from $50 in February, keeping an Overweight stance.
The P/E ratio sits at 22.87, up 1.15 points over 30 days. Price-to-book is 2.50, down 0.01 over the month. EV/EBITDA is 15.04, up 0.24 points. The stock ranks in the 90th percentile on dividend score and 64th on EPS surprise. EPS momentum over 90 days places it in the 37th percentile. Analyst recommendation differential ranks just 1st percentile.
Insiders sold a net $883 over the past 90 days, immaterial in scale. Vanguard holds 14.3% with a small add of 120,190 shares last quarter. BlackRock increased its stake by 1.4 million shares to 12.5%. UBS Asset Management added 2.5 million shares in Q4 2025.
Omega last reported February 5, with earlier prints in early February 2026. The stock closed at $46.41, up 3.8% over the past month but down 0.9% over the past week.
No ORTEX Alpha signals are currently active.
See the live data behind this article on ORTEX.
Open OHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
